Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner
Man Zhu, Xianpeng Shi, Zhengyan Gong, Qi Su, Runze Yu, Bo Wang, Tianfeng Yang, Bingling Dai, Yingzhuan Zhan, Dongdong Zhang, Yanmin Zhang
Topics & Concepts
CantharidinPI3K/AKT/mTOR pathwayHepatocellular carcinomaSTAT3Protein kinase BCancer researchMedicineSignal transductionCell biologyChemistryBiologyOrganic chemistryBeetle Biology and Toxicology StudiesCytokine Signaling Pathways and InteractionsPI3K/AKT/mTOR signaling in cancer